Balyasny Asset Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Balyasny Asset Management’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,654	Closed	-$1.69K	–	2988
2023 Q1	$1.69K	Hold	23,654	–	–	﹤0.01%	2571
2022 Q4	$1.52K	Hold	23,654	–	–	﹤0.01%	2687
2022 Q3	$2K	Hold	23,654	–	–	﹤0.01%	2773
2022 Q2	$3K	Hold	23,654	–	–	﹤0.01%	2677
2022 Q1	$9K	Hold	23,654	–	–	﹤0.01%	2409
2021 Q4	$16K	Hold	23,654	–	–	﹤0.01%	2162
2021 Q3	$16K	Hold	23,654	–	–	﹤0.01%	1867
2021 Q2	$22K	Buy	+23,654	New	+$18.9K	﹤0.01%	1908

Other funds holding AONCW

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Balyasny Asset Management's AONCW Position: Q2 2023 in Review

Balyasny Asset Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2023, closing a stake of 23,654 shares — an estimated $1.69K sold.

Balyasny Asset Management first reported a position in AONCW in Q2 2021 and held it in 8 quarters. The position peaked at $22K in Q2 2021. 46 funds tracked by Wall St. Rank hold AONCW as of Q2 2023.

Balyasny Asset Management reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 23,654 American Oncology Network, Inc. Warrant shares in Q2 2023, an estimated $1.69K.
Balyasny Asset Management first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 8 quarters.
Balyasny Asset Management's American Oncology Network, Inc. Warrant position peaked at $22K in Q2 2021.
46 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.